BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2895495)

  • 1. [Reflux esophagitis: therapeutic indications].
    Cloarec D; Bruley des Varannes S; Galmiche JP
    Rev Prat; 1988 Feb; 38(4):237-48. PubMed ID: 2895495
    [No Abstract]   [Full Text] [Related]  

  • 2. [Conservative therapy of reflux esophagitis].
    Koop H
    Z Gastroenterol Verh; 1990 Apr; 25():135-7. PubMed ID: 1694350
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of reflux esophagitis].
    Berges W; Wienbeck M
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():15-7. PubMed ID: 7910994
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug therapy of reflux oesophagitis: an update.
    Tytgat GN
    Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflux esophagitis.
    Tytgat GN; Nio CY; Schotborgh RH
    Scand J Gastroenterol Suppl; 1990; 175():1-12. PubMed ID: 1978403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of gastroesophageal reflux: the role of proton pump inhibitors.
    Schulman MI; Orlando RC
    Adv Intern Med; 1995; 40():273-302. PubMed ID: 7747649
    [No Abstract]   [Full Text] [Related]  

  • 7. Maintenance therapies for reflux esophagitis.
    Yarze JC
    N Engl J Med; 1996 Feb; 334(9):600-1. PubMed ID: 8569839
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of bronchial asthma associated with reflux esophagitis, whose peak expiratory flow rate improved with omeprazole and cisapride].
    Fujimori K; Suzuki E; Arakawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Nov; 32(11):1088-93. PubMed ID: 7815763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance therapies for reflux esophagitis.
    Grey MR
    N Engl J Med; 1996 Feb; 334(9):600-1. PubMed ID: 8569838
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative efficacy of acid reflux inhibition by drug therapy in reflux esophagitis.
    Sekiguchi T; Nishioka T; Matsuzaki T; Sugiyama M; Kusano M; Horikoshi T; Toki M; Ohwada T; Kobayashi S
    Gastroenterol Jpn; 1991 Apr; 26(2):137-44. PubMed ID: 2040397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists.
    Koop H; Hotz J; Pommer G; Klein M; Arnold R
    Aliment Pharmacol Ther; 1990 Dec; 4(6):593-9. PubMed ID: 1983342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole in infants with cimetidine-resistant peptic esophagitis.
    Alliët P; Raes M; Bruneel E; Gillis P
    J Pediatr; 1998 Feb; 132(2):352-4. PubMed ID: 9506656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisapride versus ranitidine in the treatment of reflux esophagitis.
    Janisch HD; Hüttemann W; Bouzo MH
    Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies, dilemmas, and dialogues. Reduction of gastric acidity in the treatment of peptic ulcer disease: how low should we go?
    Peterson WL; Harford WV
    Am J Gastroenterol; 1991 Jun; 86(6):671-5. PubMed ID: 1674838
    [No Abstract]   [Full Text] [Related]  

  • 15. H2 antagonists in the treatment of reflux esophagitis: a critical analysis.
    Stalnikowicz-Darvasi R
    Am J Gastroenterol; 1989 Mar; 84(3):245-8. PubMed ID: 2563926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflux esophagitis in infants and children: a report from the Working Group on Gastro-Oesophageal Reflux Disease of the European Society of Paediatric Gastroenterology and Nutrition.
    Vandenplas Y
    J Pediatr Gastroenterol Nutr; 1994 May; 18(4):413-22. PubMed ID: 7915307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
    McKenna CJ; Mills JG; Goodwin C; Wood JR
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic approaches to healing esophagitis.
    Boyce HW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):22S-27S; discussion 27S-29S. PubMed ID: 9127623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of reflux oesophagitis resistant to H2-receptor antagonists.
    Klinkenberg-Knol EC; Meuwissen SG
    Digestion; 1989; 44 Suppl 1():47-53. PubMed ID: 2575061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of reflux esophagitis with histamine H2-receptor antagonists.
    Kishi S; Tsuzi Y; Matsumura M; Kakutani A; Ito S; Mori H
    Tokushima J Exp Med; 1985 Dec; 32(3-4):65-70. PubMed ID: 2875547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.